Lupin launches Temovate generic

BALTIMORE — Lupin has launched its Clobetasol Propionate Topical Solution USP, 0.05%.

Clobetasol is the generic equivalent of Fougera Pharmaceuticals’ Temovate (clobetasol propionate) Scalp Application, 0.05%. It is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.



Temovate Clobetasol Propionate Scalp Application had an estimated U.S. sales of USD 64.1 million in 2016.